Detalhe da pesquisa
1.
TLR2-mediated innate immune priming boosts lung anti-viral immunity.
Eur Respir J
; 58(1)2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33303547
2.
The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory Infections.
J Patient Exp
; 10: 23743735231151554, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36741822
3.
TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.
JCI Insight
; 6(5)2021 03 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33561017
4.
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.
EBioMedicine
; 63: 103153, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33279857
5.
High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
Hum Gene Ther
; 13(7): 803-13, 2002 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-11975847